TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) is...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) is...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) is...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) is...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) is...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) is...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) is...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) is...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) is...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) is...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) is...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix
US Patent
Bioenergenix
US Patent
Affinity DataIC50: <1.00E+4nMAssay Description:Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) is...More data for this Ligand-Target Pair